Growth factors vs copper peptides: what the research actually shows

Last updated 2026-07-25

what's the actual difference between growth factors and copper peptides?

Growth factors are signaling proteins, usually recombinant versions of things like epidermal growth factor (EGF) or basic fibroblast growth factor (bFGF/FGF2), made in bacteria or yeast and purified for cosmetic use. They're large molecules compared to a peptide, and they work by binding specific receptors on skin cells to trigger a cascade, more collagen, more proliferation, that kind of signal. Copper peptides, in the skincare context, almost always means GHK-Cu, a tripeptide (glycyl-l-histidyl-l-lysine) bound to a copper ion. It's a much smaller molecule, occurs naturally in human plasma, and its levels decline with age. The 2018 review in the International Journal of Molecular Sciences frames GHK-Cu's action around gene expression changes tied to tissue remodeling and protection, not a single receptor-lock-and-key story ^[1]. Both categories get marketed as "anti-aging." But the mechanism story is different. Growth factors mimic a specific signal. GHK-Cu acts more like a broad modulator of copper-dependent enzymes, antioxidant pathways, and tissue remodeling genes. That's a real mechanistic distinction, more than marketing language.

which one has better clinical evidence for skin aging?

Honestly, copper peptides have the deeper and more specific literature, at least in terms of volume and mechanistic detail. The GHK-Cu record includes a 2018 gene-expression review ^[1], a 2020 anti-aging peptide review in Aging Pathobiology and Therapeutics ^[2], and a 2025 BioImpacts review focused specifically on GHK as a topical anti-wrinkle peptide that walks through its advantages and unresolved problems ^[3]. That 2025 BioImpacts paper is worth sitting with for a second, because its own title admits the tension: "advantages, problems and prospective." This isn't a settled case. It's an active area with real gaps, not a slam dunk. Growth factor cosmetics (EGF serums, FGF serums) have a real cell-culture and in-vitro literature, that part isn't invented, but the specific peer-reviewed record cataloged in this research pack sits almost entirely on the copper peptide side. If you're trying to find a stack of published mechanistic studies to actually read, GHK-Cu is where they are. That doesn't mean growth factor serums don't work at all, it means the citable, specific evidence trail here favors the copper peptide. A 2023 Journal of Cosmetic Dermatology study looked at GHK-Cu combined with hyaluronic acid and found synergistic upregulation of collagen IV in fibroblast and ex-vivo skin tests ^[4]. That's a fairly specific, testable claim, collagen IV specifically, more than "collagen" in the abstract. | Factor | Growth factors (EGF/FGF serums) | Copper peptides (GHK-Cu) |

does GHK-Cu actually help wounds heal, or is that just theoretical?

There's real animal data here, more than cell dishes. A 2017 study in Wound Repair and Regeneration found that GHK-Cu loaded into liposomes sped up healing of scald wounds in mice, with more cell proliferation and more angiogenesis (new blood vessel formation) in the treated group ^[7]. That's a specific, mechanistic wound-healing result in a live animal model, which is a step beyond a petri dish. The tissue remodeling story goes back further. A 2008 paper in the Journal of Biomaterials Science, Polymer Edition, laid out GHK's role in tissue remodeling broadly, looking at how the peptide interacts with structural proteins and signaling during repair ^[8]. This is one of the older, more foundational papers in the GHK literature and a lot of later work builds on its framing. More recent work has pushed into harder tissue and inflammation models too. A 2025 study in Colloids and Surfaces B used an injectable hydroxyapatite microsphere filler loaded with GHK-Cu and reported anti-inflammatory and antioxidant effects ^[9], and a 2025 Bioconjugate Chemistry paper on GHK-hyaluronan conjugates found antioxidant properties plus synergistic osteogenic (bone-forming) and angiogenic effects ^[10]. None of this is skin-serum research, it's biomaterials and tissue engineering work, but it shows the same molecule turning up across a surprisingly wide range of repair contexts. Growth factors don't have an equivalent published stack in this specific research pack. That's worth being honest about: it doesn't mean EGF/FGF serums have zero mechanism, it means the citable animal and biomaterials record assembled here is lopsided toward copper peptides.

is copper peptide research mostly topical, injectable, or something else entirely?

Mostly topical and mostly research-stage, with a growing side branch in orthopaedic and injectable peptide science that's a completely separate conversation. On the skin side, the challenge researchers keep circling back to is penetration. A 2025 Molecules paper asked directly whether we're even equipped to measure skin permeation of GHK-Cu when it's encapsulated in liposomes ^[5], and a related 2023 Pharmaceutics paper studied liposomes specifically as carriers for GHK-Cu in cosmetic formulation ^[6]. A 2024 Electrophoresis paper used CE-ICP-MS/MS (a specific analytical method) to monitor how well GHK-Cu actually loads into liposome carriers ^[11]. These are formulation science papers, essentially asking "how do we even get this molecule where it needs to go and prove it got there," which tells you the delivery problem is still being worked out, not solved. Separately, there's a fast-growing body of orthopaedic and sports medicine literature on injectable peptide therapies generally. A 2026 review in the Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews covers therapeutic peptides in orthopaedics broadly, including applications and challenges ^[12]. A 2026 American Journal of Sports Medicine primer specifically addresses injectable peptide therapy for orthopaedic and sports medicine physicians ^[13], and a 2026 Sports Medicine paper reviews safety and efficacy across both approved and unapproved peptide therapies used for musculoskeletal injuries and athletic performance ^[14]. None of that orthopaedic literature is the same evidence base as a copper peptide face serum. If you see injectable GHK-Cu marketed for skin, that's a completely different oversight category than a topical cosmetic, and it should be provider-reviewed, not self-administered from an online cart. For more on how sourcing and oversight actually works for topical copper peptide products, see our guide on where to buy GHK-Cu.

is copper actually safe to put on your skin or take internally?

Copper is not a substance where more is automatically better, and the research here is honest about that. Copper is an essential trace mineral your body needs for enzyme function, but excess copper is genuinely toxic; that's true of oral and systemic copper exposure generally, which is why any injectable or systemic copper peptide product needs provider oversight, not self-dosing. Topically, GHK-Cu is typically formulated at low, controlled concentrations specifically because copper delivery needs to be managed carefully. Researchers have built specific chemical sensors just to detect and quantify copper ion release from GHK-Cu, including a 2023 Journal of Organic Chemistry paper on a phenothiazine-based fluorescent sensor for GHK-Cu detection ^[15] and a 2023 Analytical Chemistry paper on label-free copper ion detection using GHK-modified nanochannels ^[16]. The fact that so much lab effort goes into precisely measuring copper release tells you researchers treat copper dosing as something that needs tight control, not something to eyeball. There's also a body of work exploring GHK-Cu's antioxidant and anti-inflammatory action in internal organ models: a 2020 Life Sciences study on bleomycin-induced pulmonary fibrosis ^[17], a 2016 Oncotarget study on lipopolysaccharide-induced acute lung injury ^[18], a 2024 Redox Biology study on silicosis-related lung fibrosis ^[19], and a 2025 Frontiers in Pharmacology study on an experimental colitis model ^[20]. These are animal studies exploring GHK-Cu's systemic anti-inflammatory potential. They are not evidence that oral or injectable copper peptide supplementation is safe or effective in humans for these conditions. Anyone combining copper supplements, copper IUDs, or multivitamins with copper peptide products should factor in cumulative copper exposure and talk to a provider, especially with any liver condition (copper is cleared through the liver and bile).

does GHK-Cu do anything for hair, or is that just a skin story extended?

The specific hair-growth clinical trial record for GHK-Cu is thinner than the skin and wound-healing record, and most of what circulates online extrapolates from the same tissue-remodeling and follicle-signaling mechanisms studied for skin. If you're specifically researching copper peptides for hair thinning or shedding, it's worth looking at how the sourcing and formulation questions play out for that use case specifically. See our breakdown of copper peptides for hair growth for how that angle is currently supported. The broader anti-aging mechanism work, like the 2020 Aging Pathobiology and Therapeutics review ^[2] and a 2026 Biogerontology study finding that GHK-Cu delays aging in C. elegans (roundworms) through mitochondrial function and DAF-16/SKN-1 pathway activation ^[21], supports a general "this peptide affects aging-related cellular pathways" story. It does not directly establish human hair regrowth outcomes. Treat hair-specific claims as extrapolated, not as a settled clinical finding.

how does GHK-Cu compare to other actives like niacinamide?

Niacinamide (vitamin B3) works through a completely different mechanism, mostly barrier support and some pigment modulation, and has a much longer, larger human clinical trial record at the concentrations typically sold over the counter. GHK-Cu's strength is a deep, specific mechanistic literature (gene expression, wound models, antioxidant pathways) but comparatively few large human randomized trials at consumer concentrations. If you're deciding between the two, or whether to layer them, the honest short answer is they're not really competing for the same job. A full side-by-side, including where they conflict in a routine and where they don't, is covered in our comparison of copper peptides vs niacinamide.

what does 'FDA-approved' actually mean for either of these ingredients?

Neither growth factor serums nor copper peptide serums sold as cosmetics are FDA-approved drugs, full stop. Cosmetic products in the US are regulated for safety and labeling, not for the efficacy claims stamped on a growth factor or copper peptide serum bottle. The FDA's own regulation on "intended use" (21 CFR 201.128) is the legal hinge here: if a product is marketed with claims that it affects the structure or function of the body in a drug-like way, that can push it into drug territory regardless of what the label calls it ^[22]. That's part of why serious cosmetic brands are careful about the specific claims they make. For compounded, provider-dispensed versions (which show up more in the injectable and clinical-use conversation than in retail skincare), the relevant framework is pharmacy compounding law under 21 U.S.C. 353a ^[23], and the FDA maintains specific lists of bulk drug substances allowed for use in compounding under Section 503A (the 503A Bulks List, 21 CFR 216.23) ^[24] and under Section 503B for outsourcing facilities (21 CFR 216.24) ^[25]. You can check the FDA's current nominated bulk substances list directly ^[26]. None of the peer-reviewed peptide studies in this article constitute FDA approval of GHK-Cu, or growth factors, as a drug for any condition; approved drug products are tracked separately in the Drugs@FDA database ^[27].

which one is actually worth the money, growth factors or copper peptides?

For topical skincare, if you want the ingredient with the deepest, most specific published mechanistic trail to actually go read, that's GHK-Cu. The 2025 BioImpacts review is a good single starting point because it's explicit about both the advantages and the unresolved problems ^[3], rather than a marketing-friendly cherry-pick. Growth factor serums aren't nonsense, but based on the sources gathered here, the citable animal-model and wound-healing record is thinner for cosmetic growth factor products specifically than it is for GHK-Cu. If a growth factor serum and a copper peptide serum cost about the same, the copper peptide one has more published mechanistic backing to point to. Where this gets more serious is anything injectable or provider-administered. That's not a skincare purchase decision anymore, it's a clinical one, and it belongs with a provider who can weigh the orthopaedic and sports medicine literature on injectable peptides ^[12][13][14] against your specific situation, not a serum comparison chart. Cosmetic-grade topical GHK-Cu and provider-dispensed compounded preparations are genuinely different products, made under different oversight, and shouldn't be treated as interchangeable just because they share three letters and a copper ion.

Frequently asked questions

are growth factors or copper peptides better for wrinkles?

GHK-Cu has a more specific published record for wrinkle-related mechanisms, including a 2025 BioImpacts review dedicated to it as an anti-wrinkle peptide ^[3] and a 2023 Journal of Cosmetic Dermatology study on collagen IV upregulation ^[4]. Growth factor cosmetics have cell-culture support but a thinner citable clinical trail in the sources reviewed here. Neither is FDA-approved as a wrinkle treatment.

can you use growth factor serum and copper peptide serum together?

There's no published study in this research pack testing that specific combination, so the honest answer is nobody has direct data on it. Formulators sometimes layer them because the proposed mechanisms differ (receptor signaling vs. copper-dependent enzyme modulation), but that's a formulation theory, not a tested clinical claim.

does copper peptide serum actually penetrate the skin?

This is an active research question, not a settled fact. A 2025 Molecules paper specifically questioned whether current methods can even reliably measure GHK-Cu skin permeation when it's encapsulated in liposomes ^[5], and separate 2023 and 2024 papers studied liposome delivery and encapsulation monitoring as unresolved formulation challenges ^[6][11].

is copper peptide the same as GHK-Cu?

In skincare, yes, "copper peptide" almost always refers to GHK-Cu, the copper complex of the tripeptide glycyl-l-histidyl-l-lysine. The peptide occurs naturally in human plasma and its levels decline with age, which is part of why it was originally studied ^[1].

is copper peptide serum safe if I already take a copper supplement?

Copper is essential but toxic in excess, and systemic copper exposure adds up across supplements, diet, IUDs, and topical products. There's no published safety data in this pack on combining oral copper supplementation with topical GHK-Cu specifically, so this is a genuine conversation to have with a provider, especially if you have liver disease.

do growth factor serums have FDA approval?

No. Growth factor serums sold as cosmetics are not FDA-approved drugs. FDA's intended-use regulation (21 CFR 201.128) governs when a product's claims push it into drug territory regardless of its ingredient list ^[22]. Check Drugs@FDA directly if you want to verify any product's approval status ^[27].

is injectable GHK-Cu the same product as a copper peptide face serum?

No, and treating them as the same is a mistake. Injectable and compounded peptide preparations fall under pharmacy compounding law (21 U.S.C. 353a) ^[23] and FDA's bulk drug substance lists for 503A and 503B ^[24][25], an entirely different oversight path than an over-the-counter cosmetic serum. Injectable use should be provider-reviewed.

does copper peptide help with hair loss?

The direct human hair-regrowth trial evidence in this research pack is thin. Most hair-related claims extrapolate from GHK-Cu's broader tissue-remodeling and anti-aging mechanism studies ^[1][2][21], not from dedicated hair-growth trials, so treat those claims as extrapolated rather than proven.

which has more research, growth factors or copper peptides, for wound healing?

Copper peptides, based on the sources reviewed here. GHK-Cu has animal wound-healing studies, including a 2017 mouse scald wound study showing faster healing with more angiogenesis ^[7], plus decades-old foundational tissue remodeling work from 2008 ^[8]. The growth factor wound-healing literature exists but wasn't as deep in this specific comparison.

why do researchers keep testing GHK-Cu in unrelated fields like lung disease and solar cells?

Because GHK-Cu's copper-binding and antioxidant chemistry is genuinely useful outside skincare. It's been studied for pulmonary fibrosis ^[17], acute lung injury ^[19], colitis ^[20], as a component in polymer solar cells ^[28], and even as a chemical sensor for copper ion detection ^[15][16]. That range reflects real chemistry, not skincare hype spreading into unrelated fields.

what's the difference between cosmetic-grade and provider-dispensed copper peptide products?

Cosmetic-grade serums are regulated as cosmetics, not drugs, and are not required to prove clinical efficacy before sale. Provider-dispensed compounded preparations fall under pharmacy compounding law and FDA's bulk substance lists ^[23][24][25], with different sourcing, purity, and oversight standards. They are not interchangeable products.

do copper peptides work better on bone or joint tissue than growth factors?

There's early biomaterials research on GHK-Cu in bone-related contexts, including a 2025 Bioconjugate Chemistry study finding synergistic osteogenic and angiogenic effects with GHK-hyaluronan conjugates ^[10] and a 2015 rat ACL reconstruction study showing GHK-Cu(II) transiently improved healing outcomes ^[29]. This is early-stage animal and biomaterials work, not a head-to-head clinical comparison against growth factor therapies.

Sources

1. International Journal of Molecular Sciences, 2018 (PMID 29986520): GHK-Cu's regenerative and protective actions are linked to gene expression data, and the peptide's natural plasma levels decline with age
2. Aging Pathobiology and Therapeutics, 2020 (PMID 35083444): Review of GHK's potential as an anti-aging peptide
3. BioImpacts, 2025 (PMID 39963574): Review of topically applied GHK as an anti-wrinkle peptide covering advantages, problems, and prospective directions
4. Journal of Cosmetic Dermatology, 2023 (PMID 37062921): GHK-Cu combined with hyaluronic acid showed synergistic collagen IV upregulation in fibroblast and ex-vivo skin tests
5. Molecules, 2025 (PMID 39795193): Paper questions whether current methods can reliably measure skin permeation of liposome-encapsulated GHK-Cu
6. Pharmaceutics, 2023 (PMID 37896245): Study of liposomes as carriers of GHK-Cu tripeptide for cosmetic application
7. Wound Repair and Regeneration, 2017 (PMID 28370978): GHK-Cu-liposomes accelerated scald wound healing in mice via increased cell proliferation and angiogenesis
8. Journal of Biomaterials Science, Polymer Edition, 2008 (PMID 18644225): Foundational paper on the human tripeptide GHK and its role in tissue remodeling
9. Colloids and Surfaces B: Biointerfaces, 2025 (PMID 40716276): Injectable hydroxyapatite microsphere filler loaded with GHK-Cu tripeptide showed anti-inflammatory and antioxidant effects
10. Bioconjugate Chemistry, 2025 (PMID 40123442): GHK-hyaluronan copper conjugates showed antioxidant properties and synergistic osteogenic and angiogenic effects
11. Electrophoresis, 2024 (PMID 39451062): CE-ICP-MS/MS method used to monitor encapsulation of antiaging GHK-Cu in liposomes
12. Journal of the American Academy of Orthopaedic Surgeons Global Research & Reviews, 2026 (PMID 41490200): Review of therapeutic peptides in orthopaedics covering applications, challenges, and future directions
13. The American Journal of Sports Medicine, 2026 (PMID 41476424): Primer on injectable peptide therapy for orthopaedic and sports medicine physicians
14. Sports Medicine, 2026 (PMID 41966639): Review of safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance
15. The Journal of Organic Chemistry, 2023 (PMID 37830186): Phenothiazine-based fluorescent sensor developed for detecting copper ions in GHK-Cu sensing applications
16. Analytical Chemistry, 2023 (PMID 37624577): Label-free detection of copper ions using GHK-modified asymmetric nanochannels
17. Life Sciences, 2020 (PMID 31809714): GHK-Cu showed protective effects in bleomycin-induced pulmonary fibrosis via anti-oxidative and anti-inflammatory pathways
18. Oncotarget, 2016 (PMID 27517151): GHK-Cu complex ameliorated lipopolysaccharide-induced acute lung injury in mice
19. Redox Biology, 2024 (PMID 38879894): GHK-Cu tripeptide complex attenuated lung inflammation and fibrosis in a silicosis model by targeting peroxiredoxin 6
20. Frontiers in Pharmacology, 2025 (PMID 40672369): Study explored beneficial effects of GHK-Cu in an experimental model of colitis and underlying mechanisms
21. Biogerontology, 2026 (PMID 42084774): GHK-Cu delayed aging in C. elegans via coordinated regulation of mitochondrial function and DAF-16/SKN-1 pathway activation
22. FDA, 21 CFR 201.128, meaning of intended uses: Defines when product claims establish drug-like intended use regardless of cosmetic labeling
23. 21 U.S.C. 353a, pharmacy compounding: Statutory framework governing pharmacy compounding of drug substances, applicable to provider-dispensed peptide preparations
24. 21 CFR 216.23, the 503A Bulks List: Lists bulk drug substances that may be used in compounding under Section 503A
25. 21 CFR 216.24, the 503B Bulks List: Lists bulk drug substances that may be used in compounding under Section 503B for outsourcing facilities
26. FDA, bulk drug substances nominated for use in compounding (current list): FDA's current list of nominated bulk drug substances under review for compounding use
27. Drugs@FDA, FDA-approved drug products database: Public database for verifying whether any specific drug product has FDA approval
28. ACS Applied Materials & Interfaces, 2021 (PMID 34546033): GHK-Cu incorporated into ternary polymer solar cells to tune crystallinity and phase separation of active layers
29. Journal of Orthopaedic Research, 2015 (PMID 25731775): GHK-Cu(II) transiently improved healing outcome in a rat model of ACL reconstruction